IFP Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.2K Hold
4,033
﹤0.01% 2974
2025
Q4
$13.6K Buy
4,033
+8
+0.2% +$21 ﹤0.01% 2914
2025
Q3
$5.27K Buy
4,025
+619
+18% +$641 ﹤0.01% 3217
2025
Q2
$2.44K Buy
3,406
+2,979
+698% +$2.34K ﹤0.01% 3805
2025
Q1
$628 Sell
427
-7
-2% -$17 ﹤0.01% 3417
2024
Q4
$1.92K Buy
+434
New +$1.76K ﹤0.01% 3116
2024
Q3
Sell
-144
Closed -$939 3377
2024
Q2
$939 Buy
+144
New +$1.02K ﹤0.01% 3001
2023
Q4
Sell
-455
Closed -$4.38K 3201
2023
Q3
$4.38K Buy
+455
New +$4.46K ﹤0.01% 2559
2023
Q1
Sell
-2,013
Closed -$38K 3917
2022
Q4
$38K Buy
2,013
+8
+0.4% +$91 ﹤0.01% 2425
2022
Q3
$38K Sell
2,005
-21
-1% -$238 ﹤0.01% 2583
2022
Q2
$38K Hold
2,026
﹤0.01% 2349
2022
Q1
$38K Buy
+2,026
New +$23.2K ﹤0.01% 2349
2020
Q4
Sell
-140
Closed -$1.53K 3018
2020
Q3
$1K Hold
140
﹤0.01% 2648
2020
Q2
$1K Hold
140
﹤0.01% 2551
2020
Q1
$1K Buy
+140
New +$1.65K ﹤0.01% 2550
2018
Q4
Sell
-59
Closed -$1K 3704
2018
Q3
$1K Sell
59
-14
-19% -$221 ﹤0.01% 3692
2018
Q2
$1K Buy
+73
New +$1.08K ﹤0.01% 3734
2017
Q3
Sell
-79
Closed -$1K 4132
2017
Q2
$1K Buy
+79
New +$1.15K ﹤0.01% 3896

Other funds holding IRWD

IFP Advisors's IRWD Position: Q1 2026 in Review

IFP Advisors held its Ironwood Pharmaceuticals (IRWD) position steady in Q1 2026 at 4,033 shares worth $14.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2974.

IFP Advisors first reported a position in IRWD in Q2 2017 and has held it in 18 quarters since. The position peaked at $38K in Q4 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • IFP Advisors held 4,033 shares of Ironwood Pharmaceuticals worth $14.2K as of Q1 2026.
  • IFP Advisors left its Ironwood Pharmaceuticals share count unchanged in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #2974 holding.
  • IFP Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2017 and has held it in 18 quarters since.
  • IFP Advisors's Ironwood Pharmaceuticals position peaked at $38K in Q4 2022.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.